Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-14 5:01 pm Sale | 2023-08-14 | 13G | BELLUS HEALTH INC BLU | RA Capital Management, L.P. | 0 0.000% | -12,452,574 (Position Closed) | Filing History |
| 2023-08-14 5:00 pm Sale | 2023-08-14 | 13G | KINNATE BIOPHARMA INC KNTE | RA Capital Management, L.P. | 0 0.000% | -4,264,144 (Position Closed) | Filing History |
| 2023-08-11 5:05 pm Purchase | 2023-08-10 | 13D | VOR BIOPHARMA INC.COM VOR | RA Capital Management, L.P. | 1,139,017 33.700% | 1,010 (+0.09%) | Filing History |
| 2023-08-11 5:01 pm Sale | 2023-08-09 | 13D | 89BIO INC ETNB | RA Capital Management, L.P. | 12,874,814 16.700% | -2,084 (-0.02%) | Filing History |
| 2023-08-09 5:00 pm Sale | 2023-08-09 | 13D | DICE THERAPEUTICS INC DICE | RA Capital Management, L.P. | 0 0.000% | -7,877,862 (Position Closed) | Filing History |
| 2023-08-01 4:30 pm Purchase | 2023-06-08 | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | RA Capital Management, L.P. | 9,333,333 11.300% | 5,000,000 (+115.38%) | Filing History |
| 2023-07-25 4:31 pm Purchase | 2023-07-21 | 13D | ACUMEN PHARMACEUTICALS INC ABOS | RA Capital Management, L.P. | 14,981,618 25.900% | 5,207,067 (+53.27%) | Filing History |
| 2023-07-06 4:32 pm Purchase | 2023-06-26 | 13G | TALARIS THERAPEUTICS INC TALS | RA Capital Management, L.P. | 233,318 5.500% | 233,318 (New Position) | Filing History |
| 2023-07-06 4:30 pm Purchase | 2023-06-26 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA Capital Management, L.P. | 347,069 9.990% | 347,069 (New Position) | Filing History |
| 2023-06-27 5:00 pm Purchase | 2023-06-26 | 13D | AEROVATE THERAPEUTICS INC AVTE | RA Capital Management, L.P. | 236,947 30.000% | 833 (+0.35%) | Filing History |
| 2023-06-21 5:00 pm Purchase | 2023-06-18 | 13D | DICE THERAPEUTICS INC DICE | RA Capital Management, L.P. | 7,877,862 16.500% | 217,247 (+2.84%) | Filing History |
| 2023-06-12 5:00 pm Sale | 2023-06-08 | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA Capital Management, L.P. | 0 0.000% | -5,944,252 (Position Closed) | Filing History |
| 2023-06-05 4:31 pm Purchase | 2023-05-25 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA Capital Management, L.P. | 2,789,721 6.700% | 2,789,721 (New Position) | Filing History |
| 2023-05-30 5:00 pm Purchase | 2023-05-25 | 13D | ICOSAVAX INC ICVX | RA Capital Management, L.P. | 5,985,843 12.500% | 206,496 (+3.57%) | Filing History |
| 2023-05-15 5:02 pm Sale | 2023-05-15 | 13G | TRAVERE THERAPEUTICS INC TVTX | RA Capital Management, L.P. | 0 0.000% | -3,984,681 (Position Closed) | Filing History |
| 2023-05-15 5:01 pm Sale | 2023-05-15 | 13G | DA32 LIFE SCIENCE TECH ACQUISI DALS | RA Capital Management, L.P. | 0 0.000% | -1,500,000 (Position Closed) | Filing History |
| 2023-05-15 5:01 pm Sale | 2023-05-15 | 13G | ARYA SCIENCES ACQUISITION CORP ARYE | RA Capital Management, L.P. | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2023-04-18 4:30 pm Purchase | 2009-02-28 | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA Capital Management, L.P. | 5,944,252 17.900% | 30,000 (+0.51%) | Filing History |
| 2023-04-10 5:05 pm Purchase | 2023-03-30 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | RA Capital Management, L.P. | 2,577,373 5.500% | 2,433,473 (+1691.09%) | Filing History |
| 2023-04-10 5:01 pm Purchase | 2023-04-06 | 13D | CLIMB BIO, INC. CLYM | RA Capital Management, L.P. | 13,163,071 48.800% | 11,112 (+0.08%) | Filing History |